News

The anti-GPC3 targeted therapies market is expected to witness growth in the coming years, driven by the increasing incidence of cancer cases, clinical pipeline activity, and anticipated regulatory ...
CRISPR Therapeutics could stage a comeback thanks to clinical and commercial progress. There are many promising corporations ...
We are investigating so-called anti-CRISPRs: proteins or other molecules that phages use to inhibit CRISPR. A bacterium that has CRISPR might be able to stop a phage from infecting. But if the phage ...
For entrepreneurs in this space, the challenge is clear: Harness the momentum without falling into the trap of hype. Build ...
Researchers have successfully 3D printed insulin-producing human pancreas cells that could revolutionize treatment for Type 1 ...
During a live event, Alfred L. Garfall, MD, discussed talquetamab dosing strategies and efficacy after dose reduction in ...
The NOX-targeted therapy market is expected to expand significantly over the upcoming years as more therapies move into ...
Detailed price information for Meiragtx Holdings Plc (MGTX-Q) from The Globe and Mail including charting and trades.
As the global population grows, we’ll have to find ways of feeding the planet without accelerating climate change.
CD8⁺ T cells are the immune system's frontline warriors, charged with detecting and eliminating cancer cells. But in the ...